Frontiers in Oncology | Hematologic Malignancies

Review

Published on 17 Feb 2021

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

in Hematologic Malignancies

Massimo Offidani
Laura Corvatta
Sonia Morè
Davide Nappi
Giovanni Martinelli
Attilio Olivieri
Claudio Cerchione

Frontiers in Oncology

doi 10.3389/fonc.2020.624661

31,190 views
62 citations

Review

Published on 16 Feb 2021

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

in Hematologic Malignancies

Douglas Tremblay
Heidi E. Kosiorek
Amylou C. Dueck
Ronald Hoffman

Frontiers in Oncology

doi 10.3389/fonc.2020.636675

8,295 views
12 citations

Original Research

Published on 15 Feb 2021

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients

in Hematologic Malignancies

Francesca Cottini
Ying Huang
Nita Williams
Naresh Bumma
Abdullah M. Khan
Maria Chaudhry
Srinivas Devarakonda
Yvonne A. Efebera
Don M. Benson
Ashley E. Rosko

Frontiers in Oncology

doi 10.3389/fonc.2020.575168

6,172 views
15 citations

Editorial

Published on 09 Feb 2021

Editorial: Cutaneous T-Cell Lymphomas

in Hematologic Malignancies

Catherine G. Chung
Basem M. William

Frontiers in Oncology

doi 10.3389/fonc.2021.649714

2,237 views

Review

Published on 09 Feb 2021

Game of Bones: How Myeloma Manipulates Its Microenvironment

in Hematologic Malignancies

Tyler Moser-Katz
Nisha S. Joseph
Madhav V. Dhodapkar
Kelvin P. Lee
Lawrence H. Boise

Frontiers in Oncology

doi 10.3389/fonc.2020.625199

12,021 views
49 citations

Review

Published on 08 Feb 2021

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

in Hematologic Malignancies

Matteo Molica
Carla Mazzone
Pasquale Niscola
Paolo de Fabritiis

Frontiers in Oncology

doi 10.3389/fonc.2020.610820

40,004 views
68 citations

Original Research

Published on 05 Feb 2021

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells

in Hematologic Malignancies

Ernestina Saulle
Isabella Spinello
Maria Teresa Quaranta
Luca Pasquini
Elvira Pelosi
Egidio Iorio
Germana Castelli
Mattea Chirico
Maria Elena Pisanu
Tiziana Ottone

Frontiers in Oncology

doi 10.3389/fonc.2020.621458

10,686 views
53 citations

Original Research

Published on 05 Feb 2021

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome

in Hematologic Malignancies

Ming-Jing Wang
Wei-Yi Liu
Xue-Ying Wang
Yu-Meng Li
Hai-Yan Xiao
Ri-Cheng Quan
Gang Huang
Xiao-Mei Hu

Frontiers in Oncology

doi 10.3389/fonc.2020.606928

3,639 views
4 citations

Correction

Published on 05 Feb 2021

Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Elda Pereira Noronha
Luísa Vieira Codeço Marques
Francianne Gomes Andrade
Luiz Claudio Santos Thuler
Eugênia Terra-Granado
Maria S. Pombo-de-Oliveira
the Brazilian Collaborative Study Group of Acute Leukemia
Carolina da Paz Zampier
Thayana da Conceição Barbosa
Paulo Chagas Neto

Frontiers in Oncology

doi 10.3389/fonc.2020.640629

1,700 views
1 citation

Mini Review

Published on 05 Feb 2021

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia

in Hematologic Malignancies

Yinjun Lou
Yafang Ma
Jie Jin
Honghu Zhu

Frontiers in Oncology

doi 10.3389/fonc.2020.597601

7,211 views
24 citations

Review

Published on 03 Feb 2021

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis

in Hematologic Malignancies

Gregory P. Kaufman
Claudio Cerchione

Frontiers in Oncology

doi 10.3389/fonc.2020.624573

8,876 views
6 citations

Review

Published on 02 Feb 2021

Maintenance Therapy in AML

in Hematologic Malignancies

Patrick K. Reville
Tapan M. Kadia

Frontiers in Oncology

doi 10.3389/fonc.2020.619085

22,729 views
30 citations

Original Research

Published on 29 Jan 2021

Solasonine Suppresses the Proliferation of Acute Monocytic Leukemia Through the Activation of the AMPK/FOXO3A Axis

in Hematologic Malignancies

Hong Zhang
Fang Tian
Pengjun Jiang
Shushu Qian
Xingbin Dai
Bangyun Ma
Mengya Wang
Huibo Dai
Xiaocao Sha
Zhongfa Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.614067

5,433 views
23 citations

Original Research

Published on 29 Jan 2021

The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer

in Hematologic Malignancies

Alexander C. Leeksma
Ingrid A. M. Derks
M. Haidar Kasem
Emine Kilic
Annelies de Klein
Martine J. Jager
Arjan A. van de Loosdrecht
Joop H. Jansen
Veronika Navrkalova
Laura M. Faber

Frontiers in Oncology

doi 10.3389/fonc.2020.609409

9,004 views
21 citations

Brief Research Report

Published on 29 Jan 2021

Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR

in Hematologic Malignancies

Qiumei Yao
Yinlei Bai
Shaji Kumar
Elaine Au
Alberto Orfao
Chor Sang Chim

Frontiers in Oncology

doi 10.3389/fonc.2020.611021

4,560 views
6 citations

Original Research

Published on 28 Jan 2021

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations

in Hematologic Malignancies

Sarah A. Bannon
Mark J. Routbort
Guillermo Montalban-Bravo
Rohtesh S. Mehta
Fatima Zahra Jelloul
Koichi Takahashi
Naval Daver
Betul Oran
Naveen Pemmaraju
Gautam Borthakur

Frontiers in Oncology

doi 10.3389/fonc.2020.582213

14,192 views
60 citations

Review

Published on 27 Jan 2021

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities

in Hematologic Malignancies

Leona Yamamoto
Nicola Amodio
Annamaria Gulla
Kenneth Carl Anderson

Frontiers in Oncology

doi 10.3389/fonc.2020.606368

12,131 views
38 citations

Original Research

Published on 27 Jan 2021

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma

in Hematologic Malignancies

Xiaolei Wei
Jingxia Zheng
Zewen Zhang
Qiongzhi Liu
Minglang Zhan
Weimin Huang
Junjie Chen
Qi Wei
Yongqiang Wei
Ru Feng

Frontiers in Oncology

doi 10.3389/fonc.2020.610681

4,349 views
18 citations

Review

Published on 25 Jan 2021

PET/CT in Multiple Myeloma: Beyond FDG

in Hematologic Malignancies

Federica Matteucci
Giovanni Paganelli
Giovanni Martinelli
Claudio Cerchione

Frontiers in Oncology

doi 10.3389/fonc.2020.622501

21,147 views
30 citations

Case Report

Published on 25 Jan 2021

Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure

in Hematologic Malignancies

Gloria Taliani
Elena Follini
Lorenzo Guglielmetti
Patrizia Bernuzzi
Alberto Faggi
Patrizia Ferrante
Elisa Fronti
Laura Gerna
Maria Cristina Leoni
Franco Paolillo

Frontiers in Oncology

doi 10.3389/fonc.2020.582901

5,621 views
4 citations

Case Report

Published on 20 Jan 2021

Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature

in Hematologic Malignancies

Xuewei Li
Nana Ping
Yong Wang
Xiaoyu Xu
Lijuan Gao
Zhao Zeng
Ling Zhang
Zhibo Zhang
Yiyu Xie
Changgeng Ruan

Frontiers in Oncology

doi 10.3389/fonc.2020.584149

6,186 views
12 citations

Perspective

Published on 18 Jan 2021

Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?

in Hematologic Malignancies

Edoardo Giussani
Andrea Binatti
Giulia Calabretto
Vanessa Rebecca Gasparini
Antonella Teramo
Cristina Vicenzetto
Gregorio Barilà
Monica Facco
Alessandro Coppe
Gianpietro Semenzato

Frontiers in Oncology

doi 10.3389/fonc.2020.613570

3,570 views
5 citations

Original Research

Published on 18 Jan 2021

Elevated Red Blood Cell Distribution Width as a Poor Prognostic Factor in Patients With Hematopoietic Stem Cell Transplantation

in Hematologic Malignancies

Xiaojiong Jia
Si Cheng
Long Zhang
Yuan Zheng
Hua Zou
Shifeng Huang
Hongxu Wang
Juan Lu
Dijiao Tang

Frontiers in Oncology

doi 10.3389/fonc.2020.565265

4,874 views
3 citations

Review

Published on 15 Jan 2021

Telomere Dysfunction in Chronic Lymphocytic Leukemia

in Hematologic Malignancies

Billy Michael Chelliah Jebaraj
Stephan Stilgenbauer

Frontiers in Oncology

doi 10.3389/fonc.2020.612665

7,813 views
27 citations

2,071 articles

articles

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients

Editorial: Cutaneous T-Cell Lymphomas

Game of Bones: How Myeloma Manipulates Its Microenvironment

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome

Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia

Oral Realgar-Indigo Naturalis Formula Plus Retinoic Acid for Acute Promyelocytic Leukemia

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis

Maintenance Therapy in AML

Solasonine Suppresses the Proliferation of Acute Monocytic Leukemia Through the Activation of the AMPK/FOXO3A Axis

The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer

Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCR

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma

PET/CT in Multiple Myeloma: Beyond FDG

Case Report: B Lymphocyte Disorders Under COVID-19 Inflammatory Pressure

Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature

Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?

Elevated Red Blood Cell Distribution Width as a Poor Prognostic Factor in Patients With Hematopoietic Stem Cell Transplantation

Telomere Dysfunction in Chronic Lymphocytic Leukemia